Cover Image
市場調查報告書

心臟輔助裝置:醫療設備的開發平台評估

Cardiac Assist Devices - Medical Devices Pipeline Assessment, 2015

出版商 GlobalData 商品編碼 351422
出版日期 內容資訊 英文 323 Pages
訂單完成後即時交付
價格
Back to Top
心臟輔助裝置:醫療設備的開發平台評估 Cardiac Assist Devices - Medical Devices Pipeline Assessment, 2015
出版日期: 2016年01月05日 內容資訊: 英文 323 Pages
簡介

本報告提供心臟輔助裝置的開發中產品相關調查,提供您各開發階段趨勢和產品的主要開發企業,現在進行中的臨床實驗,產業的最近事件等資訊。

第1章 目錄

第2章 簡介

  • 心臟輔助裝置概要

第3章 開發中的產品

  • 開發中產品:各開發階段
  • 開發中產品:各市場區隔
  • 開發中產品:地區 (國家) 別
  • 開發中產品:法規途徑別
  • 開發中產品:核准時期別 (估計)
  • 進行中臨床實驗

第4章 心臟輔助裝置 - 正在開發的開發中產品:各企業

  • 開發企業 - 開發中產品:各開發階段
  • 開發中產品:各開發階段

第5章 心臟輔助裝置的開發企業與產品概要

  • Abiomed, Inc.
  • Acorn Cardiovascular, Inc.
  • Arrow International Cr, A.S.
  • Biophan Technologies, Inc.
  • BioQ Devices Pty Ltd
  • BioVentrix, Inc.
  • BiVacor Pty Ltd
  • Braile Biomedica Ltda.
  • Calon Cardio-Technology Ltd
  • Cardiac Power Inc.
  • CardiacAssist, Inc.
  • Cardiak Ltd.
  • CARDIAnove
  • Cardio Vox, Inc.
  • CardioBridge GmbH
  • CardioKinetix, Inc.
  • CardioPlus, Inc.
  • Carmat SAS
  • Charite - Universitatsmedizin Berlin
  • Cleveland Heart, Inc.
  • CorasMedical
  • CorAssist Cardiovascular Ltd.
  • CorInnova, Inc.
  • CorWave
  • Drexel University
  • DUALIS MedTech GmbH
  • Ension, Inc.
  • Evaheart, Inc.
  • Everheart Systems, LLC
  • Foster-Miller, Inc. (Inactive)
  • Fundacion para la Investigacion Biomedica del Hospital Gregorio Maranon
  • Gold Medical Technologies, Inc.
  • Harvard University
  • HeartWare International, Inc.
  • Jarvik Heart, Inc.
  • LaunchPoint Technologies, Inc.
  • Leviticus Cardio Ltd.
  • Levram Medical Systems Ltd
  • Lonestar Heart, Inc.
  • Mayo Clinic.
  • MicroMed Cardiovascular, Inc.
  • Microstim GmbH
  • MyoCardioCare, Inc.
  • MyoPowers Medical Technologies SA
  • NeoCardial Technologies, LLC
  • New Heart
  • Nipro Corporation
  • NuVascular Technologies Inc
  • Orqis Medical Corporation
  • Penn State Milton S. Hershey Medical Center
  • Perfusion Solutions
  • PlugMed Heart SAS
  • Procyrion
  • Purdue University
  • QRS Diagnostic, LLC
  • ReliantHeart, Inc.
  • Saint Louis University
  • St. Jude Medical, Inc.
  • Sunshine Heart Company, Pty. Ltd.
  • SynCardia Systems, Inc.
  • Teleflex Incorporated
  • Terumo Corporation
  • The Artificial Heart Laboratory of Foundation for Cardiac Surgery Development
  • The University of Tokyo
  • U.S. Stem Cell, Inc.
  • University of Minnesota
  • University of Zurich
  • Vadovations, Inc.
  • Vienna University of Technology
  • Windmill Cardiovascular Systems, Inc.

第6章 心臟輔助裝置 - 最近的事件

第7章 附錄

目錄
Product Code: GDME0142EPD

GlobalData's Medical Devices sector report, "Cardiac Assist Devices - Medical Devices Pipeline Assessment, 2015" provides an overview of Cardiac Assist Devices currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Cardiac Assist Devices pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Cardiac Assist Devices under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Cardiac Assist Devices and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Cardiac Assist Devices under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. Cardiac Assist Devices Overview

3. Products under Development

  • 3.1. Cardiac Assist Devices - Pipeline Products by Stage of Development
  • 3.2. Cardiac Assist Devices - Pipeline Products by Segment
  • 3.3. Cardiac Assist Devices - Pipeline Products by Territory
  • 3.4. Cardiac Assist Devices - Pipeline Products by Regulatory Path
  • 3.5. Cardiac Assist Devices - Pipeline Products by Estimated Approval Date
  • 3.6. Cardiac Assist Devices - Ongoing Clinical Trials

4. Cardiac Assist Devices - Pipeline Products under Development by Companies

  • 4.1. Cardiac Assist Devices Companies - Pipeline Products by Stage of Development
  • 4.2. Cardiac Assist Devices - Pipeline Products by Stage of Development

5. Cardiac Assist Devices Companies and Product Overview

  • 5.1. Abiomed, Inc. Company Overview
    • 5.1.1. Abiomed, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.2. Acorn Cardiovascular, Inc. Company Overview
    • 5.2.1. Acorn Cardiovascular, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.3. Arrow International Cr, A.S. Company Overview
    • 5.3.1. Arrow International Cr, A.S. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.4. Biophan Technologies, Inc. Company Overview
    • 5.4.1. Biophan Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.5. BioQ Devices Pty Ltd Company Overview
    • 5.5.1. BioQ Devices Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.6. BioVentrix, Inc. Company Overview
    • 5.6.1. BioVentrix, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.7. BiVacor Pty Ltd Company Overview
    • 5.7.1. BiVacor Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.8. Braile Biomedica Ltda. Company Overview
    • 5.8.1. Braile Biomedica Ltda. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.9. Calon Cardio-Technology Ltd Company Overview
    • 5.9.1. Calon Cardio-Technology Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.10. Cardiac Power Inc. Company Overview
    • 5.10.1. Cardiac Power Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.11. CardiacAssist, Inc. Company Overview
    • 5.11.1. CardiacAssist, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.12. Cardiak Ltd. Company Overview
    • 5.12.1. Cardiak Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.13. CARDIAnove Company Overview
    • 5.13.1. CARDIAnove Pipeline Products & Ongoing Clinical Trials Overview
  • 5.14. Cardio Vox, Inc. Company Overview
    • 5.14.1. Cardio Vox, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.15. CardioBridge GmbH Company Overview
    • 5.15.1. CardioBridge GmbH Pipeline Products & Ongoing Clinical Trials Overview
  • 5.16. CardioKinetix, Inc. Company Overview
    • 5.16.1. CardioKinetix, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.17. CardioPlus, Inc. Company Overview
    • 5.17.1. CardioPlus, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.18. Carmat SAS Company Overview
    • 5.18.1. Carmat SAS Pipeline Products & Ongoing Clinical Trials Overview
  • 5.19. Charite - Universitatsmedizin Berlin Company Overview
    • 5.19.1. Charite - Universitatsmedizin Berlin Pipeline Products & Ongoing Clinical Trials Overview
  • 5.20. Cleveland Heart, Inc. Company Overview
    • 5.20.1. Cleveland Heart, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.21. CorasMedical Company Overview
    • 5.21.1. CorasMedical Pipeline Products & Ongoing Clinical Trials Overview
  • 5.22. CorAssist Cardiovascular Ltd. Company Overview
    • 5.22.1. CorAssist Cardiovascular Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.23. CorInnova, Inc. Company Overview
    • 5.23.1. CorInnova, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.24. CorWave Company Overview
    • 5.24.1. CorWave Pipeline Products & Ongoing Clinical Trials Overview
  • 5.25. Drexel University Company Overview
    • 5.25.1. Drexel University Pipeline Products & Ongoing Clinical Trials Overview
  • 5.26. DUALIS MedTech GmbH Company Overview
    • 5.26.1. DUALIS MedTech GmbH Pipeline Products & Ongoing Clinical Trials Overview
  • 5.27. Ension, Inc. Company Overview
    • 5.27.1. Ension, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.28. Evaheart, Inc. Company Overview
    • 5.28.1. Evaheart, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.29. Everheart Systems, LLC Company Overview
    • 5.29.1. Everheart Systems, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.30. Foster-Miller, Inc. (Inactive) Company Overview
    • 5.30.1. Foster-Miller, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
  • 5.31. Fundacion para la Investigacion Biomedica del Hospital Gregorio Maranon Company Overview
    • 5.31.1. Fundacion para la Investigacion Biomedica del Hospital Gregorio Maranon Pipeline Products & Ongoing Clinical Trials Overview
  • 5.32. Gold Medical Technologies, Inc. Company Overview
    • 5.32.1. Gold Medical Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.33. Harvard University Company Overview
    • 5.33.1. Harvard University Pipeline Products & Ongoing Clinical Trials Overview
  • 5.34. HeartWare International, Inc. Company Overview
    • 5.34.1. HeartWare International, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.35. Jarvik Heart, Inc. Company Overview
    • 5.35.1. Jarvik Heart, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.36. LaunchPoint Technologies, Inc. Company Overview
    • 5.36.1. LaunchPoint Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.37. Leviticus Cardio Ltd. Company Overview
    • 5.37.1. Leviticus Cardio Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.38. Levram Medical Systems Ltd Company Overview
    • 5.38.1. Levram Medical Systems Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.39. Lonestar Heart, Inc. Company Overview
    • 5.39.1. Lonestar Heart, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.40. Mayo Clinic. Company Overview
    • 5.40.1. Mayo Clinic. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.41. MicroMed Cardiovascular, Inc. Company Overview
    • 5.41.1. MicroMed Cardiovascular, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.42. Microstim GmbH Company Overview
    • 5.42.1. Microstim GmbH Pipeline Products & Ongoing Clinical Trials Overview
  • 5.43. MyoCardioCare, Inc. Company Overview
    • 5.43.1. MyoCardioCare, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.44. MyoPowers Medical Technologies SA Company Overview
    • 5.44.1. MyoPowers Medical Technologies SA Pipeline Products & Ongoing Clinical Trials Overview
  • 5.45. NeoCardial Technologies, LLC Company Overview
    • 5.45.1. NeoCardial Technologies, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.46. New Heart Company Overview
    • 5.46.1. New Heart Pipeline Products & Ongoing Clinical Trials Overview
  • 5.47. Nipro Corporation Company Overview
    • 5.47.1. Nipro Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • 5.48. NuVascular Technologies Inc Company Overview
    • 5.48.1. NuVascular Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.49. Orqis Medical Corporation Company Overview
    • 5.49.1. Orqis Medical Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • 5.50. Penn State Milton S. Hershey Medical Center Company Overview
    • 5.50.1. Penn State Milton S. Hershey Medical Center Pipeline Products & Ongoing Clinical Trials Overview
  • 5.51. Perfusion Solutions Company Overview
    • 5.51.1. Perfusion Solutions Pipeline Products & Ongoing Clinical Trials Overview
  • 5.52. PlugMed Heart SAS Company Overview
    • 5.52.1. PlugMed Heart SAS Pipeline Products & Ongoing Clinical Trials Overview
  • 5.53. Procyrion Company Overview
    • 5.53.1. Procyrion Pipeline Products & Ongoing Clinical Trials Overview
  • 5.54. Purdue University Company Overview
    • 5.54.1. Purdue University Pipeline Products & Ongoing Clinical Trials Overview
  • 5.55. QRS Diagnostic, LLC Company Overview
    • 5.55.1. QRS Diagnostic, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.56. ReliantHeart, Inc. Company Overview
    • 5.56.1. ReliantHeart, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.57. Saint Louis University Company Overview
    • 5.57.1. Saint Louis University Pipeline Products & Ongoing Clinical Trials Overview
  • 5.58. St. Jude Medical, Inc. Company Overview
    • 5.58.1. St. Jude Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.59. Sunshine Heart Company, Pty. Ltd. Company Overview
    • 5.59.1. Sunshine Heart Company, Pty. Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.60. SynCardia Systems, Inc. Company Overview
    • 5.60.1. SynCardia Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.61. Teleflex Incorporated Company Overview
    • 5.61.1. Teleflex Incorporated Pipeline Products & Ongoing Clinical Trials Overview
  • 5.62. Terumo Corporation Company Overview
    • 5.62.1. Terumo Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • 5.63. The Artificial Heart Laboratory of Foundation for Cardiac Surgery Development Company Overview
    • 5.63.1. The Artificial Heart Laboratory of Foundation for Cardiac Surgery Development Pipeline Products & Ongoing Clinical Trials Overview
  • 5.64. The University of Tokyo Company Overview
    • 5.64.1. The University of Tokyo Pipeline Products & Ongoing Clinical Trials Overview
  • 5.65. U.S. Stem Cell, Inc. Company Overview
    • 5.65.1. U.S. Stem Cell, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.66. University of Minnesota Company Overview
    • 5.66.1. University of Minnesota Pipeline Products & Ongoing Clinical Trials Overview
  • 5.67. University of Zurich Company Overview
    • 5.67.1. University of Zurich Pipeline Products & Ongoing Clinical Trials Overview
  • 5.68. Vadovations, Inc. Company Overview
    • 5.68.1. Vadovations, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.69. Vienna University of Technology Company Overview
    • 5.69.1. Vienna University of Technology Pipeline Products & Ongoing Clinical Trials Overview
  • 5.70. Windmill Cardiovascular Systems, Inc. Company Overview
    • 5.70.1. Windmill Cardiovascular Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview

6. Cardiac Assist Devices- Recent Developments

7. Appendix

  • 7.1. Methodology
  • 7.2. About GlobalData
  • 7.3. Contact Us
  • 7.4. Disclaimer

List of Tables

  • Table 1: Cardiac Assist Devices - Pipeline Products by Stage of Development
  • Table 2: Cardiac Assist Devices - Pipeline Products by Segment
  • Table 3: Cardiac Assist Devices - Pipeline Products by Territory
  • Table 4: Cardiac Assist Devices - Pipeline Products by Regulatory Path
  • Table 5: Cardiac Assist Devices - Pipeline Products by Estimated Approval Date
  • Table 6: Cardiac Assist Devices - Ongoing Clinical Trials
  • Table 7: Cardiac Assist Devices Companies - Pipeline Products by Stage of Development
  • Table 8: Cardiac Assist Devices - Pipeline Products by Stage of Development
  • Table 9: Abiomed, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 10: AbioCor II - Product Status
  • Table 11: AbioCor II - Product Description
  • Table 12: Impella 5.0/LD - High Risk PCI - Product Status
  • Table 13: Impella 5.0/LD - High Risk PCI - Product Description
  • Table 14: Impella CP - High Risk PCI - Product Status
  • Table 15: Impella CP - High Risk PCI - Product Description
  • Table 16: Impella Pediatric Pump - Product Status
  • Table 17: Impella Pediatric Pump - Product Description
  • Table 18: Symphony Heart Pump - Product Status
  • Table 19: Symphony Heart Pump - Product Description
  • Table 20: Acorn Cardiovascular, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 21: CorCap Cardiac Support Device - Product Status
  • Table 22: CorCap Cardiac Support Device - Product Description
  • Table 23: Acorn Cardiovascular, Inc. - Ongoing Clinical Trials Overview
  • Table 24: CorCap Cardiac Support Device - Clinical Evaluation Of Acorn CorCap Cardiac Support Device Concomitant To MVR - A Confirmatory Trial
  • Table 25: Arrow International Cr, A.S. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 26: CorAide Left Ventricular Assist System - Product Status
  • Table 27: CorAide Left Ventricular Assist System - Product Description
  • Table 28: Biophan Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 29: Myotech Circulatory Support System - Product Status
  • Table 30: Myotech Circulatory Support System - Product Description
  • Table 31: BioQ Devices Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Table 32: BioQ IntraAortic Counterpulsation Prosthesis - Product Status
  • Table 33: BioQ IntraAortic Counterpulsation Prosthesis - Product Description
  • Table 34: BioVentrix, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 35: Next Generation Revivent System - Product Status
  • Table 36: Next Generation Revivent System - Product Description
  • Table 37: PliCath HF - Product Status
  • Table 38: PliCath HF - Product Description
  • Table 39: BioVentrix, Inc. - Ongoing Clinical Trials Overview
  • Table 40: PliCath HF - Phase II Study of the BioVentrix PliCath HF System for the Treatment of Ischemic Cardiomyopathy.
  • Table 41: PliCath HF - This Study is a Multi-center, Prospective, Single-armed, Study Designed to Evaluate the Safety and Feasibility of the BioVentrix PliCath HF System for Left Ventricular (LV) Volume and Radius Reduction Through Scar Exclusion in Patients Whose Systolic HF is Due to Ischemic Cardiomyopathy
  • Table 42: BiVacor Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Table 43: BiVACOR Device - Product Status
  • Table 44: BiVACOR Device - Product Description
  • Table 45: Braile Biomedica Ltda. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 46: Blood Pump - Product Status
  • Table 47: Blood Pump - Product Description
  • Table 48: Calon Cardio-Technology Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Table 49: BridgeVAD - Product Status
  • Table 50: BridgeVAD - Product Description
  • Table 51: Calon MiniVAD - Product Status
  • Table 52: Calon MiniVAD - Product Description
  • Table 53: CathVAD - Product Status
  • Table 54: CathVAD - Product Description
  • Table 55: Cardiac Power Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 56: Repower - Product Status
  • Table 57: Repower - Product Description
  • Table 58: CardiacAssist, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 59: TandemHeart Circulatory Support System - Product Status
  • Table 60: TandemHeart Circulatory Support System - Product Description
  • Table 61: CardiacAssist, Inc. - Ongoing Clinical Trials Overview
  • Table 62: TandemHeart Circulatory Support System - TandemHeart Experiences and Methods (THEME Registry)
  • Table 63: Cardiak Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 64: Akpulsor - Product Status
  • Table 65: Akpulsor - Product Description
  • Table 66: CARDIAnove Pipeline Products & Ongoing Clinical Trials Overview
  • Table 67: CARDIAnove Pump - Product Status
  • Table 68: CARDIAnove Pump - Product Description
  • Table 69: Cardio Vox, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 70: Transcatheter Ventricular Assist Device - Product Status
  • Table 71: Transcatheter Ventricular Assist Device - Product Description
  • Table 72: CardioBridge GmbH Pipeline Products & Ongoing Clinical Trials Overview
  • Table 73: 10F RCP System - Product Status
  • Table 74: 10F RCP System - Product Description
  • Table 75: 14F RCP System - Product Status
  • Table 76: 14F RCP System - Product Description
  • Table 77: CardioKinetix, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 78: Parachute Ventricular Partitioning Device - Product Status
  • Table 79: Parachute Ventricular Partitioning Device - Product Description
  • Table 80: CardioKinetix, Inc. - Ongoing Clinical Trials Overview
  • Table 81: Parachute Ventricular Partitioning Device - A Dual-Arm, Open-Label, Multi-Center Registry Designed To Evaluate The Parachute Implant in Ischemic Heart Failure Patients
  • Table 82: Parachute Ventricular Partitioning Device - A Multinational Trial To Evaluate the Parachute Implant System: Parachute Percutaneous Ventricular Restoration in Chronic Heart Failure Due to Ischemic Heart Disease
  • Table 83: Parachute Ventricular Partitioning Device - PARACHUTE III: A Multinational Trial to Evaluate the Longterm Safety of the Parachute System
  • Table 84: Parachute Ventricular Partitioning Device - Percutaneous Ventricular Restoration in Chronic Heart Failure Due to Ischemic Heart Disease
  • Table 85: CardioPlus, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 86: CardioPlus - Product Status
  • Table 87: CardioPlus - Product Description
  • Table 88: Carmat SAS Pipeline Products & Ongoing Clinical Trials Overview
  • Table 89: Artificial Heart - Product Status
  • Table 90: Artificial Heart - Product Description
  • Table 91: Carmat SAS - Ongoing Clinical Trials Overview
  • Table 92: Artificial Heart - First-in-man CARMAT's Bioprosthetic Heart Trial For End-stage Heart Failure
  • Table 93: Charite - Universitatsmedizin Berlin Pipeline Products & Ongoing Clinical Trials Overview
  • Table 94: Low - Stress Rotary Blood Pump - Product Status
  • Table 95: Low - Stress Rotary Blood Pump - Product Description
  • Table 96: Cleveland Heart, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 97: SmartHeart LVAD - Product Status
  • Table 98: SmartHeart LVAD - Product Description
  • Table 99: SmartHeart TAH - Product Status
  • Table 100: SmartHeart TAH - Product Description
  • Table 101: CorasMedical Pipeline Products & Ongoing Clinical Trials Overview
  • Table 102: CORAS Hotor - Product Status
  • Table 103: CORAS Hotor - Product Description
  • Table 104: CorAssist Cardiovascular Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 105: CORolla - Product Status
  • Table 106: CORolla - Product Description
  • Table 107: ImCardia - Product Status
  • Table 108: ImCardia - Product Description
  • Table 109: CorAssist Cardiovascular Ltd. - Ongoing Clinical Trials Overview
  • Table 110: CORolla - CORolla TAA for Heart Failure and Preserved Ejection Fraction and Diastolic Dysfunction
  • Table 111: CORolla - CORolla TAA for Heart Failure with Preserved Ejection Fraction (HFpEF) and Diastolic Dysfunction (DD) Safety and Feasibility
  • Table 112: CorInnova, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 113: CardiacSTAR - Bridge To Decision - Product Status
  • Table 114: CardiacSTAR - Bridge To Decision - Product Description
  • Table 115: CardiacSTAR - Bridge To Recovery - Product Status
  • Table 116: CardiacSTAR - Bridge To Recovery - Product Description
  • Table 117: CardiacSTAR - Bridge To Transplant - Product Status
  • Table 118: CardiacSTAR - Bridge To Transplant - Product Description

List of Figures

  • Figure 1: Cardiac Assist Devices - Pipeline Products by Stage of Development
  • Figure 2: Cardiac Assist Devices - Pipeline Products by Segment
  • Figure 3: Cardiac Assist Devices - Pipeline Products by Territory
  • Figure 4: Cardiac Assist Devices - Pipeline Products by Regulatory Path
  • Figure 5: Cardiac Assist Devices - Pipeline Products by Estimated Approval Date
  • Figure 6: Cardiac Assist Devices - Ongoing Clinical Trials
Back to Top